Surveillance of Antimicrobial Resistance in the ECOWAS Region: Setting the Scene for Critical Interventions Needed
Authors:
- Ahmed Taha AboushadyAAAhmed Taha Aboushady
- Olivier ManigartOMOlivier Manigart
- Abdourahmane SowASAbdourahmane Sow
- Walter FullerWFWalter Fuller
- Abdoul-Salam OuedraogoAOAbdoul-Salam Ouedraogo
- Chinelo EbrukeCEChinelo Ebruke
- François-Xavier BabinFBFrançois-Xavier Babin
- Laetitia GahimbareLGLaetitia Gahimbare
- Issiaka SombiéISIssiaka Sombié
- John StellingJSJohn Stelling
Open Access
- 5 July 2024
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 13 (7) , 627
Abstract
Antimicrobial resistance poses a significant challenge to public health globally, leading to increased morbidity and mortality. AMR surveillance involves the systematic collection, analysis, and interpretation of data on the occurrence and distribution of AMR in humans, animals, and the environment for action. The West African Health Organization, part of the Economic Community of West African States (ECOWAS), is committed to addressing AMR in the region. This paper examines the status of AMR surveillance in ECOWAS countries using available WHO data from the TrACSS survey and GLASS enrollments. The analysis reveals that while progress has been made, significant challenges remain. Twelve of the fifteen ECOWAS countries are enrolled in GLASS, and ten have developed national action plans (NAPs) for AMR. However, there is a need to ensure all countries fully implement their NAPs, continue reporting to GLASS, and use the data for evidence-based actions and decision making. Surveillance systems for AMR and antimicrobial consumption/use vary across countries with some demonstrating limited capacity. All countries, except Cabo Verde, reported having a reference laboratory for AMR testing. Strengthening laboratory capabilities, data management and use, and multisectoral coordination are crucial for effective AMR surveillance and response. Based on the findings and the regional context, it is essential to prioritize capacity building, data utilization, and the adoption of standardized guidelines for AMR surveillance. Collaboration among ECOWAS countries, the WAHO, and international partners is essential to address AMR comprehensively. Ensuring a consistent supply of essential antimicrobial medications and reagents is vital.Keywords
Funding Information
- Fleming Fund Strategic Alignment Grants (FF117-525)
This publication has 49 references indexed in Scilit:
- Attributable Patient Cost of Antimicrobial Resistance: A Prospective Parallel Cohort Study in Two Public Teaching Hospitals in GhanaPharmacoEconomics - Open, 2023
- EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approachThe Lancet Regional Health - Europe, 2022
- Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysisClinical Microbiology and Infection, 2022
- Promoting cross-regional collaboration in antimicrobial stewardship: Findings of an infectious diseases working group survey in Arab countries of the Middle EastJournal of Infection and Public Health, 2021
- Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countriesClinical Microbiology and Infection, 2021
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet, 2020
- A five-year retrospective study shows increasing rates of antimicrobial drug resistance in Cabo Verde for both Staphylococcus aureus and Escherichia coliJournal of Global Antimicrobial Resistance, 2020
- Characteristics of One Health surveillance systems: A systematic literature reviewPreventive Veterinary Medicine, 2020
- Global economic impact of antibiotic resistance: A reviewJournal of Global Antimicrobial Resistance, 2019
- Antibiotic Use and Emerging Resistance: How Can Resource-Limited Countries Turn the Tide?Global Heart, 2014